KIMBELL HALL: Open Payments
NPI 1659083343 · ALEDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,749 in 107 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,239 · 2025 $2,749
Food & beverage: $2,749
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $546 |
| Novartis Pharmaceuticals Corporation | 14 | $395 |
| Regeneron Healthcare Solutions, Inc. | 11 | $277 |
| LEO Pharma Inc. | 9 | $277 |
| Incyte Corporation | 8 | $209 |
| Galderma Laboratories, L.P. | 10 | $171 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 10 | $151 |
| ABBVIE INC. | 6 | $142 |
| Arcutis Biotherapeutics, Inc. | 5 | $104 |
| UCB, Inc. | 3 | $93 |
Products named: DUPIXENT, COSENTYX, ANZUPGO, OPZELURA, NEMLUVIO, Cabtreo, Zoryve, Bimzelx.
Industry payments across TX — which companies pay providers there.
